Related references
Note: Only part of the references are listed.An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: the influence of the reference standard on algorithm performance
Jessica Widdifield et al.
BMC MUSCULOSKELETAL DISORDERS (2014)
Tumor Necrosis Factor α Inhibitor Use and Decreased Risk for Incident Coronary Events in Rheumatoid Arthritis
Androniki Bili et al.
ARTHRITIS CARE & RESEARCH (2014)
Time Trends in Glucocorticoid Use in Rheumatoid Arthritis: Results From a Population-Based Inception Cohort, 1980-1994 Versus 1995-2007
Ashima Makol et al.
ARTHRITIS CARE & RESEARCH (2014)
Arthritis: its prevalence, risk factors, and association with cardiovascular diseases in the United States, 1999 to 2008
Kwok Leung Ong et al.
ANNALS OF EPIDEMIOLOGY (2013)
Systematic Review and Critical Appraisal of Validation Studies to Identify Rheumatic Diseases in Health Administrative Databases
Jessica Widdifield et al.
ARTHRITIS CARE & RESEARCH (2013)
Physicians' explanations for apparent gaps in the quality of rheumatology care: Results from the US Medicare Physician Quality Reporting System
Jeffrey R. Curtis et al.
ARTHRITIS CARE & RESEARCH (2013)
Changes in Use of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States During 1983-2009
Seoyoung C. Kim et al.
ARTHRITIS CARE & RESEARCH (2013)
Treatment of rheumatoid arthritis in the Medicare Current Beneficiary Survey
Daniel H. Solomon et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Factors Associated With the Initiation of Disease-Modifying Antirheumatic Drugs in Newly Diagnosed Rheumatoid Arthritis: A Retrospective Claims Database Study
Machaon M. K. Bonafede et al.
CLINICAL THERAPEUTICS (2012)
Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey
Daniel H. Solomon et al.
ARTHRITIS CARE & RESEARCH (2012)
2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis
Jasvinder A. Singh et al.
ARTHRITIS CARE & RESEARCH (2012)
Receipt of Disease-Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis in Medicare Managed Care Plans
Gabriela Schmajuk et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
The epidemiology of early inflammatory arthritis
Johanna M. W. Hazes et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Validation of rheumatoid arthritis diagnoses in health care utilization data
Seo Young Kim et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Is the Incidence of Rheumatoid Arthritis Rising? Results From Olmsted County, Minnesota, 1955-2007
Elena Myasoedova et al.
ARTHRITIS AND RHEUMATISM (2010)
Direct Comparison of Treatment Responses, Remission Rates, and Drug Adherence in Patients With Rheumatoid Arthritis Treated With Adalimumab, Etanercept, or Infliximab Results From Eight Years of Surveillance of Clinical Practice in the Nationwide Danish DANBIO Registry
Merete Lund Hetland et al.
ARTHRITIS AND RHEUMATISM (2010)
Association between Residences in US Northern Latitudes and Rheumatoid Arthritis: A Spatial Analysis of the Nurses' Health Study
Veronica M. Vieira et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2010)
A Comparison of Patient Characteristics and Outcomes in Selected European and US Rheumatoid Arthritis Registries
Jeffrey R. Curtis et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Prevalence of Specific Types of Arthritis and Other Rheumatic Conditions in the Ambulatory Health Care System in the United States, 2001-2005
Jeffrey J. Sacks et al.
ARTHRITIS CARE & RESEARCH (2010)
The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study
Frederick Wolfe et al.
ARTHRITIS RESEARCH & THERAPY (2010)
DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists
Federico Navarro-Sarabia et al.
BMC MUSCULOSKELETAL DISORDERS (2009)
Changing Patterns of Tumor Necrosis Factor Inhibitor Use in 9074 Patients with Rheumatoid Arthritis
Yusuf Yazici et al.
JOURNAL OF RHEUMATOLOGY (2009)
Utilization Trends of Tumor Necrosis Factor Inhibitors Among Patients with Rheumatoid Arthritis in a United States Observational Cohort Study
Susan J. Lee et al.
JOURNAL OF RHEUMATOLOGY (2009)
Tumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohort
Jeffrey D. Greenberg et al.
AMERICAN JOURNAL OF MEDICINE (2008)
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
Kenneth G. Saag et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population
C. G. Grijalva et al.
RHEUMATOLOGY (2008)
Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug
K. L. Hyrich et al.
RHEUMATOLOGY (2008)
Treatment response to a second or third TNF-inhibitor in RA:: results from the South Swedish Arthritis Treatment Group Register
J. A. Karisson et al.
RHEUMATOLOGY (2008)
Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state medicaid program: A retrospective, cross-sectional, descriptive, database analysis
Rahul Khanna et al.
CLINICAL THERAPEUTICS (2007)
Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal
Gabriela Schmajuk et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: A systematic review
Yannis Alamanos et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2006)
Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry
AL Weaver et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
A review of uses of health care utilization databases for epidemiologic research on therapeutics
S Schneeweiss et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2005)
The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century
D Symmons et al.
RHEUMATOLOGY (2002)
Share Paper
